Literature DB >> 1508337

Correction of apathic-abulic manifestations of the processual defect by cholinotropic preparations.

A V Golenkov, V O Lukin.   

Abstract

Mesh:

Substances:

Year:  1992        PMID: 1508337     DOI: 10.1007/bf01196912

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


× No keyword cloud information.
  7 in total

1.  [The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases].

Authors:  G Huber
Journal:  Nervenarzt       Date:  1983-01       Impact factor: 1.214

2.  [Theoretical and practical aspects of the pharmacology of cholinergic processes].

Authors:  P P Denisenko
Journal:  Farmakol Toksikol       Date:  1980 Sep-Oct

Review 3.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

4.  Schizophrenia as dopamine-deficiency disease.

Authors:  G Chouinard; B D Jones
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

5.  Positive and negative schizophrenic symptoms and the role of dopamine.

Authors:  A V Mackay
Journal:  Br J Psychiatry       Date:  1980-10       Impact factor: 9.319

6.  The two-syndrome concept: origins and current status.

Authors:  T J Crow
Journal:  Schizophr Bull       Date:  1985       Impact factor: 9.306

7.  [Method of treating parkinsonism with metamizil in combination with galanthamine (clinico-experimental basis)].

Authors:  N A Losev; V K Kamenetskiĭ
Journal:  Zh Nevropatol Psikhiatr Im S S Korsakova       Date:  1985
  7 in total
  1 in total

Review 1.  Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.

Authors:  Enrique L M Ochoa; Jose Lasalde-Dominicci
Journal:  Cell Mol Neurobiol       Date:  2007-08       Impact factor: 5.046

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.